Resultados de la búsqueda 341-350 of 13232 for Acute cholecystitis

1. Hematología - Ensayos clínicos - Mayo Clinic

   In particular, we plan to bank blood and bone marrow from patients with newly diagnoses or relapsed acute leukemia (AML or ALL) for future biological studies.

2. Hematología - Ensayos clínicos - Mayo Clinic

   In particular, we plan to bank blood and bone marrow from patients with newly diagnoses or relapsed acute leukemia (AML or ALL) for future biological studies.

3. Hematología - Ensayos clínicos - Mayo Clinic

   In particular, we plan to bank blood and bone marrow from patients with newly diagnoses or relapsed acute leukemia (AML or ALL) for future biological studies.

4. Radiología - Ensayos clínicos - Mayo Clinic

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore ...

5. Primary mediastinal large B-cell lymphoma

   Shortness of breath or difficulty breathing. Swelling in the face, neck, or arms; Feeling of fullness within the head. Headaches. Confusion in severe cases.

6. Hematología - Ensayos clínicos - Mayo Clinic

   In particular, we plan to bank blood and bone marrow from patients with newly diagnoses or relapsed acute leukemia (AML or ALL) for future biological studies.

7. Hematología - Ensayos clínicos - Mayo Clinic

   In particular, we plan to bank blood and bone marrow from patients with newly diagnoses or relapsed acute leukemia (AML or ALL) for future biological studies.

8. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

   These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...

9. Cirugía - Ensayos clínicos - Mayo Clinic

   To evaluate the safety and efficacy of Siegel™ TAVR System in the treatment of subjects with symptomatic severe native aortic stenosis. BoxX-NoAF Clinical Trial.

10. Oncología (médica) - Ensayos clínicos

    Safety is defined as any acute grade 3 (CTCAE v5.0) or greater unplanned adverse event from the time of enrollment until 4 weeks following postoperative ...